U-M findings reveal how certain genes activate cells that cause rheumatoid arthritis; discovery may extend to other autoimmune diseases.
In one of the first genome-wide studies to hunt for both genes and their regulatory “tags” in patients suffering from a common disease, researchers have found a clear role for the tags in mediating genetic risk for rheumatoid arthritis (RA). The scientists say they were able to spot tagged DNA sequences that may be important for the development of RA.
Study shows that autoimmune disease patients fail to take medications as prescribed.
Patients suffering from the painful autoimmune disease, Sjogren’s Syndrome, will soon be able to be properly diagnosed much earlier, thanks to the discovery of novel antibodies by researchers at the University at Buffalo and Immco Diagnostics, Inc.
Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, according to a new study by researchers at Hospital for Special Surgery.
University of Utah medical researchers have identified a way to treat inflammation while potentially minimizing a serious side effect of current medications: the increased risk for infection.
Genetic changes that protected their ancestors against fly-borne parasites may partly explain why African-Americans with lupus are up to five times more likely to develop end-stage kidney disease than those of European descent.
Refuting a belief long held by many physicians, a Mayo Clinic study found that rheumatoid arthritis patients also can get gout. The research is among several studies Mayo Clinic is presenting at the American College of Rheumatology annual meeting in Washington.
Using sonograms, or ultrasound technology, to measure inflammation of the joint lining (synovitis) and detect joint damage may be a useful, less expensive tool in the examination of the effects of rheumatoid arthritis, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Washington, D.C.
Being more physically active in childhood is linked to greater knee cartilage and tibial bone area in adulthood, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Washington, D.C.
Being overweight is linked to a higher risk of rheumatoid arthritis in women, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Washington, D.C.
Depression is higher in men and women with rheumatoid arthritis, and may increase mortality in this population, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Washington, D.C.
Older women with osteoarthritis who view themselves as dependent on others because they seek help to perform daily activities — such as housework — experience more sadness and depressed moods, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Washington, D.C.
According to research presented this week at the American College of Rheumatology Annual Meeting in Washington, D.C. differences by income and geographic region may prevent Medicare recipients with rheumatoid arthritis from receiving the latest RA treatments.
According to research presented this week at the American College of Rheumatology Annual Meeting in Washington, D.C., Medicare patients with rheumatoid arthritis may face higher drug costs and barriers to newer medications.
According to research presented this week at the American College of Rheumatology Annual Meeting in Washington, D.C., the total cost of treating Canadians with osteoarthritis will quadruple over the next two decades to reach $8.1 billion by the year 2031.
According to research presented this week at the American College of Rheumatology Annual Meeting in Washington, D.C., early and effective treatment by a rheumatologist may halt disease progression in people with rheumatoid arthritis.
Mobile phone monitoring in people with rheumatoid arthritis increases the likelihood that people with the disease will follow treatment, according to research presented this week at the American College of Rheumatology Annual Meeting in Washington, D.C.
According to research presented this week at the American College of Rheumatology Annual Meeting in Washington, D.C., treatment with biologic medications may reduce the risk of premature death in people with rheumatoid arthritis.
According to research presented this week at the American College of Rheumatology Annual Meeting in Washington, D.C., prescribing anti-tumor necrosis factor drugs (also called anti-TNF) to treat rheumatoid arthritis may reduce the requirement for hospital admissions. The study also found that using anti-TNF therapy significantly reduced the need for hip and knee surgery procedures, resulting in more than $21 million in overall Irish health care cost savings.
According to research presented this week at the American College of Rheumatology Annual Meeting in Washington, D.C., pain experienced by people with fibromyalgia may be caused by a problem with the way pain stimuli are processed in the brain. Abnormal pain signal processing may also be related to a lack of responsiveness to opioids, a common class of pain relievers.
A new study presented this week at the American College of Rheumatology Annual Meeting in Washington D.C., suggests that anti-tumor necrosis factor drugs (also called anti-TNF) offer no relief to patients with chronic pain caused from hand osteoarthritis.
The presence of autoantibodies in the blood may be connected to a higher risk of the development of cardiovascular disease, not just in individuals with diagnosed autoimmune diseases like rheumatoid arthritis, but in the general population, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Washington, D.C.
Extending the time between doses, or tapering, TNF-inhibitor drugs in people with rheumatoid arthritis in remission can be done in some patients without significantly increasing disease activity or impairing joint function, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Washington, D.C.
Two new studies by researchers at Hospital for Special Surgery have overturned common beliefs about joint replacement in patients with lupus and rheumatoid arthritis.
A randomized, double-blind clinical trial by researchers at Hospital for Special Surgery has revealed that corticosteroids are more effective than the more expensive treatment in providing pain relief to patients with thumb arthritis.
A new study provides the first estimates of the prevalence of antiphospholipid antibodies in patients suffering from pregnancy loss, stroke, myocardial infarction and deep vein thrombosis.
New research suggests that statins, traditionally used for cholesterol lowering, could be used in the management of individuals who are at risk for developing clotting because they have autoimmune antiphospholipid antibodies (aPL).
High rates of systemic lupus erythematosus have been linked to living in proximity to a former uranium ore processing facility in Ohio, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Washington, D.C.
WebMD Answers offers consumers access to answers from leading health organizations.
A study that included more than 45,000 residents of Sweden with rheumatoid arthritis finds that individuals with this disease had an associated higher risk of venous thromboembolism (a blood clot that forms within a vein), and that this elevated risk was stable for 10 years after the time of diagnosis
Working with mice, Johns Hopkins researchers say they have developed a gene-based therapy to stop the rodent equivalent of the autoimmune disease myasthenia gravis by specifically targeting the destructive immune response the disorder triggers in the body.
Scientists may be one step closer to predicting the uncertain course of relapsing-remitting multiple sclerosis (MS), a disease that can lay dormant for months or years, thanks to the discovery of a unique genetic marker. The marker, detailed by researchers in the August edition of The Journal of Immunology, is the first of its kind to be directly linked to MS.
Disease causes AIDS-like symptoms.
Rheumatoid arthritis alone is painful and disabling, but it also puts patients at higher risk of death. The greater susceptibility to infections that accompanies the autoimmune disorder is one reason.
Largest systematic review provides the most current information on class of drugs available to patients.
Rep. Buerkle’s (R-NY) bill calls for a national autoimmune disease committee and curriculum.
Celebrity autoimmune disease advocates and “virtual walkers” pitch-in with support.
In the realm of deadly and disabling diseases, conditions such as cancer and Alzheimer’s seem to attract the most media attention. But there are others that take a similarly high toll, and rheumatoid arthritis is one of them, Mayo Clinic researchers say.
Superstars Jack Osbourne, Kim Kardashian, Oprah Winfrey and Venus Williams have all have been diagnosed with autoimmune diseases
Benaroya Research Institute and Novo Nordisk collaborate on autoimmune disease research. Groundbreaking agreement aims to achieve better, faster diagnosis and treatment of rheumatoid arthritis, inflammatory bowel disease and lupus.
FREE conference is open to autoimmune patients, their families, healthcare providers, and the general public.
A simple blood test may help physicians track the progression of rheumatoid arthritis disease activity, say researchers at UAB. The international research team says that a blood test measuring 12 biomarkers for RA is a valid and potentially useful tool in managing the disease.
An overactive thyroid gland, or hyperthyroidism, may increase the risk of hospitalization for heart and blood-vessel disease even after surgery to remove the gland, according to a new study. The results will be presented Saturday at The Endocrine Society’s 94th Annual Meeting in Houston.
Psoriasis is an autoimmune disorder in which skin cells proliferate out of control. For some hard-to-heal wounds, the problem is just the opposite: Restorative skin cells don’t grow well or fast enough. In a paper published in the June 21, 2012 issue of Immunity, researchers at the University of California, San Diego School of Medicine describe a molecule that may lead to new treatments for both problems.
Ten-year-old Cheyanne Campo has achieved a lofty goal, despite – and because of – a sometimes painful disease. She has raised more than $500 for the Arthritis Foundation and will be participating in the organization’s annual Arthritis Walk on June 23 in Battery Park.
Type 1 Diabetes, Multiple Sclerosis, Celiac Disease and Lupus diagnoses are on the rise.
First ever Autoimmune Walk to be held in Manhattan.
Larger-than-normal populations of specific gut bacteria may trigger the development of diseases like rheumatoid arthritis and possibly fuel disease progression in people genetically predisposed to this crippling and confounding condition, say the researchers, who are participating in the Mayo Illinois Alliance for Technology Based Healthcare.
Special echocardiograms show promise for early detection of a potentially deadly complication in rheumatoid arthritis: heart disease, Mayo Clinic research shows.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right